EX-FILING FEES 5 d300057dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

CALCULATION OF FILING FEE TABLE

Form S-8

Novo Nordisk A/S

Newly Registered Securities

 

                         
     Security
Type		  

Security
Class

Title

   Fee
Calculation
Rule		  

Amount

Registered

  

Proposed
Maximum
Offering
Price

Per Unit

  

Proposed Maximum

Aggregate Offering

Price

  

Fee

Rate

  

Amount of

Registration
Fee(3)

 

Carry
Forward
Form

Type

   Carry
Forward
File
Number		   Carry
Forward
Initial
Effective
Date		   Filing Fee
Previously
Paid in
Connection
with Unsold
Securities to
be Carried
Forward
                         

Fees to be

Paid

   Equity   B shares, nominal value DKK 0.20 per share   Rule 457(c) and Rule 457(h)   5,000,000(1)(2)   $109.60   $548,000,000.00   $92.70 per $1,000,000.00   $50,799.60   —     —     —     —  
                         

Fees

Previously

Paid

   —     —     —     —     —     —     —     —     —     —     —     —  
 
Carry Forward Securities
                   

Carry

Forward

Securities

   —     —     —     —     —     —     —     —     —  
                   
    Total Offering Amounts     $548,000,000.00     $50,799.60          
                   
    Total Fees Previously Paid         —            
                   
    Total Fee Offsets         —            
                   
    Net Fee Due               $50,799.60                

 

(1)

The B shares may be represented by American Depository Shares (“ADSs”) of Novo Nordisk A/S (the “Registrant”), which are evidenced by American Depositary Receipts (“ADRs”). The ADSs have been registered under a separate registration statement filed by the Registrant with the U.S. Securities and Exchange Commission (the “Commission”) on Form F-6 on December 10, 2013 (File No. 333-192740), as amended by the Post-Effective Amendment No. 1 to Form F-6 filed by the Registrant with the Commission on March 2, 2017 (File No. 333-192740). Each ADS and ADR represents one B share. The Registrant’s ADRs are listed on the New York Stock Exchange (“NYSE”) under the symbol “NVO.”

(2)

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form S-8 (this “Registration Statement”) also covers such additional shares as may hereinafter be offered or issued to prevent dilution resulting from stock splits, stock dividends, recapitalizations, or similar transactions.

(3)

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and Rule 457(h) under the Securities Act, based upon the average of the high and low sales prices of the Registrant’s ADRs as reported by the NYSE on March 22, 2022, which date is within five business days prior to filing this Registration Statement.